Andreas Hottinger

Andreas F. Hottinger, MD, PhD, is the founding director of the Brain and Spine Tumor Center of at the CHUV, Lausanne University Hospital & Lausanne University.

He is board-certified in both oncology and neurology and trained at the Lausanne University Hospital (internal medicine), Bern University Hospital (neurology), Geneva University Hospital (oncology) and Memorial Sloan Kettering Cancer Center in New York (fellowship in neuro-oncology).

Having graduated from the MSKCC Clinical Research Methodology Curriculum, he is an expert in the development of clinical trials and is responsible for the development of clinical trials in neuro-oncology in his institution. He has been a principal investigator for several phase I-III clinical trials using various immunotherapy approaches and focuses on developing these trials in the most effective way possible to maximize the chances of success.

He has co-authored more than 100 original publications in peer-reviewed journals and is an internationally recognized expert in the management of patients with high- and low-grade gliomas and primary CNS lymphomas and is a member of the panels that developed the guidelines for the American Society of Oncology (ASCO), Society of Neurooncology (SNO) and European Association of Neuro-Oncology (EANO).